期刊文献+

混合胶束在口服递药系统的研究进展 被引量:3

Research Advances of Mixed Micelles in Oral Drug Delivery System
原文传递
导出
摘要 口服给药因简便易操作、不直接损伤机体皮肤或粘膜、生产成本低、可用于长期给药等优点被大多数患者接受。然而,许多药物由于溶解度低、稳定性差和较低的渗透性等因素而难以跨越胃肠道粘膜屏障,导致口服生物利用度低。研究发现,结构和性能相似的载体材料可在水溶液中自发形成混合胶束体系用于包载难溶性药物。与传统的单一胶束制剂相比,混合胶束因具有更好的稳定性、更高的载药量和更强的抗稀释能力而备受关注。将混合胶束用于口服给药系统有助于显著提高难溶性药物在水中的溶解度,保护其免遭胃肠道消化液的降解,增加药物在吸收部位的浓度,从而促进药物的口服吸收。文章结合具体实例,综述了混合胶束在口服给药系统中的最新进展,以为后续研究提供参考。 As the most common way of drug delivery,oral administration is simple and convenient for operating. It has no direct damage to the skin or mucous membrane,and can be used for long-term treatment. Along with the low cost of production,oral administration has been accepted by most of the patients. However,a lot of drugs are limited to cross gastrointestinal mucosa barrier due to their low water-solubility,poor stability and permeability,which results in undesirable oral bioavailability. Recent studies have demonstrated that carrier materials with similar structure and prosperities could self-assembly form mixed micelles in water to encapsulate poorly soluble drugs. Compared with conventional single micelles,mixed micelles show many advantages,such as better stability,higher drug loading and greater ability to resist the dilution of digestive juice in the gastrointestinal tract,and therefore,has been received much attention. The mixed micelles which are designed as oral drug delivery carrier can improve the drug solubility,protect them from degradation and increase drug concentration in absorption site to enhance the oral bioavailability of loading drugs.Combining with selected examples from literatures,this review is to provide a summary on the recent advances of mixed micelles for oral drug delivery,thereby guiding the further studies.
出处 《药物生物技术》 CAS 2016年第1期78-81,共4页 Pharmaceutical Biotechnology
关键词 混合胶束 口服给药 药物传递系统 增溶 生物利用度 肿瘤 Mixed micelles Oral administration Drug delivery system Solubilization Bioavailability Tumor
  • 相关文献

参考文献29

  • 1Aisner J. Overview of the changing paradigm in cancer treatment : oral chemotherapy [ J ]. Am J Health-Syst Pharm, 2007,64 ( 9 ) : S4-7.
  • 2Sareen S, Mathew G, Joseph L. Improvement insolubility of poor water-solubledrugs by solid dispersion[ J]. lnt J Pharm Investig, 2012,2 ( 1 ) :12-17.
  • 3Owen SC, Chan DPY, Shoichet MS. Polymeric mieelle stability [ J]. Nano Today,2012,7( 1 ) :53-65.
  • 4陈倩,孙勇.配体修饰聚合物胶束的研究进展[J].中国新药与临床杂志,2014,33(1):14-18. 被引量:2
  • 5Kedar U, Phutane P, Shidhaye S, et al. Advances in polymeric mi- celles for drug delivery and tumor targeting [ J ]. Nanomedicine, 2010,6(6) :714-729. A.
  • 6ttia ABE, Ong ZY, Hedrick JL, et al. Mixed micelles self-assem- bly from block copolymers for drug delivery [ J ]. Curr Opin Colliod In,2011,16(3) :182-194.
  • 7Zhao LY, Du JC, Duan YW, et al. Cureumin loaded mixed micelles composed of Pluronic P123 and 1768 :preparation,optimi- zation and in vitro characterization [ J ]. Colloid SugCace B, 2012, 97(9) :101-108.
  • 8Gaucher G, Satturwar P, Jones MC, et al. Polymeric micelles for oral drug delivery [ J ]. Eur J Pharm Biopharm, 2010,76 ( 2 ) : 147-158.
  • 9赵艳丽,葛建君,李艳丽,李凌冰.紫杉醇口服聚电解质复合物胶束的制备及体外评价[J].药物生物技术,2014,21(1):31-36. 被引量:2
  • 10范晓慧,赵艳丽,徐巍,李凌冰.半胱氨酸修饰的荷载紫杉醇聚离子复合物胶束口服给药的体内体外研究[J].药物生物技术,2015,22(2):95-99. 被引量:4

二级参考文献58

  • 1Li-mei HAN Jie GUO Li-jun ZHANG Qing-song WANG Xiao-ling FANG.Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123[J].Acta Pharmacologica Sinica,2006,27(6):747-753. 被引量:7
  • 2MU L, FENG SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol) [J]. J Control Release, 2002, 80 ( 1-3 ) : 129-144.
  • 3DINTAMAN JM, SILVERMAN JA. Inhibition of P-glyco-protein by D - c - toeopheryl polyethylene glycol 1000 succinate (TPGS) [J]. Pharm Res, 1999, 16(10): 1550-1556.
  • 4CAO N, FENG SS. Doxorubicin conjugated to D- alpha- tocopheryl polyethylene glycol 1000 suceinate (TPGS) : conjugation chemistry, characterization, in vitro and in vivo evaluation[J]. Biomaterials, 2008, 29(28): 3856-3865.
  • 5ANBHARASI V, CAO N, FENG SS. Doxorubicin conjugated to D-alpha-toeopheryl polyethylene glycol sueeinate and folic acid as a prodrug for targeted chemotherapy[J]. J Biomed Mater Res A, 2010, 94(3): 730-743.
  • 6MI Y, ZHAO J, FENG SS. Vitamin E TPGS prodrug micelles for hydrophilie drug delivery with neuroproteetive effects[J]. Int J Pharm, 2012, 438(1-2): 98-106.
  • 7SADOQI M, LAU- CAM CA, WU SH. Investigation of the micellar properties of the tocopheryl polyethylene glycol succinate surfactants TPGS 400 and TPGS 1000 by steady state fluorometry[J]. J Colloid Interface Sci, 2009, 333 (2) : 585-589.
  • 8XU H, ABE H, NAITO M, et all. Efficient dispersing and shortening of super- growth carbon nanotubes by ultrasonic treatment with ceramic balls and surfactants [J]. Adv Powder Technol, 2010, 21(5): 551-555.
  • 9YAN A, yon dem BUSSCHE A, KANE AB, et al. Toeopheryl polyethylene glycol suecinate as a safe, antioxidant surfaetant for processing carbon nanotubes and fullerenes [J]. Carbon N Y,2007, 45(13): 2463-2470.
  • 10CHANDRASEKHARAN P, MAITY D, YONG CX, et al. Vitamin E (D-alpha-tocopheryl-co-poly (ethylene glycol) 1000 succinate) micelles superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI[J]. Biomaterials, 2011, 32 (24) : 5663-5672.

共引文献23

同被引文献26

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部